Regulation of Cardiac Myocyte Differentiation

心肌细胞分化的调节

• 批准号: 7266456
• 负责人: David M BADER
• 金额: $ 38.04万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1986
• 资助国家: 美国
• 起止时间: 1986-09-30 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7266456
• 关键词: Regulation; Cardiac; Myocyte; Differentiation

DESCRIPTION (provided by applicant): The proposed studies are of broad importance and impact because developmental defects in the heart can lead to problems in embryogenesis but also problems that are manifested in childhood or even adult life. Control of cardiac myocyte division, shape and vesicular transport is critical for cardiac morphogenesis. While regulation of these events by a single gene may seem improbable, our recently published studies demonstrate that Lek1 plays critical roles in regulation of cell division, shape and transport. The major criticism of the original application was that we lacked data supporting Lek1 function in cardiac myocytes and that inhibition of Lek1 function was not linked to any developmental defect or cardiac disease. We now demonstrate that 1) Lek1 regulates these critical functions in cardiac myocytes and that 2) conditional disruption of the Lek1 gene results in developmental abnormalities of the heart wall leading to dilated cardiomyopathy. These new data lead us to the central hypothesis that Lek1 plays a central role in cardiac morphogenesis and that mutation of this gene leads to impaired function in the differentiated heart. Three straightforward aims will test this hypothesis. The first aim will determine whether changes in cardiac myocyte division, growth and/or apoptosis account for the "small heart" phenotype. This will be accompanied by physiological analyses of the postnatal heart to determine whether the normal adaptation of the myocyte is disrupted. The second aim will quantify the degree and timing of vesicular transport disruption in the developing and postnatal heart using GLUT4 trafficking as a model. The second part of this aim is more speculative but simple in terms of its analysis. Namely, we will determine how generation and maintenance of the intercalated disc is altered with mutation of the Lek1 gene. This will not only serve as a model for vesicular transport and myocyte shape but provide critical insight into regulation of the disc which is essential for cardiac function. The third aim focuses on determining the specific roles of nuc- and cyt-LEK1 in heart development. This will be accomplished using transgenic "rescue" of the Lek1-/- heart. No other group has the genetic, molecular, immunochemical or cell biological tools needed to elucidate the function of this unique gene in cardiac development and disease.

描述（由申请人提供）：拟议的研究具有广泛的重要性和影响力，因为心脏的发育缺陷可能导致胚胎发生问题，而且也会导致儿童甚至成年生活中出现的问题。心肌细胞分裂、形状和囊泡运输的控制对于心脏形态发生至关重要。虽然通过单个基因调节这些事件似乎不太可能，但我们最近发表的研究表明 Lek1 在细胞分裂、形状和运输的调节中发挥着关键作用。最初申请的主要批评是我们缺乏支持心肌细胞中 Lek1 功能的数据，并且 Lek1 功能的抑制与任何发育缺陷或心脏病无关。我们现在证明 1) Lek1 调节心肌细胞中的这些关键功能，2) Lek1 基因的条件性破坏会导致心壁发育异常，从而导致扩张型心肌病。这些新数据使我们得出一个中心假设：Lek1 在心脏形态发生中发挥核心作用，并且该基因的突变会导致分化心脏的功能受损。三个简单的目标将检验这一假设。第一个目标将确定心肌细胞分裂、生长和/或凋亡的变化是否是“小心脏”表型的原因。这将伴随着对出生后心脏的生理分析，以确定肌细胞的正常适应是否被破坏。第二个目标是使用 GLUT4 运输作为模型来量化发育中和出生后心脏中囊泡运输中断的程度和时间。该目标的第二部分更具推测性，但分析简单。也就是说，我们将确定 Lek1 基因突变如何改变闰盘的生成和维持。这不仅可以作为囊泡运输和肌细胞形状的模型，而且可以为椎间盘的调节提供重要的见解，这对于心脏功能至关重要。第三个目标侧重于确定 nuc-和 cyt-LEK1 在心脏发育中的具体作用。这将通过 Lek1-/- 心脏的转基因“拯救”来完成。没有其他团队拥有阐明这种独特基因在心脏发育和疾病中的功能所需的遗传、分子、免疫化学或细胞生物学工具。